# Predictive Markers of Immune-related Adverse Events in Patients Treated With Immune Stimulatory Drugs

> **NCT03984318** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 1240 (actual)

## Conditions studied

- Cancer

## Interventions

- **PROCEDURE:** Blood sample

## Key facts

- **NCT ID:** NCT03984318
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-12-12
- **Primary completion:** 2026-12-11
- **Final completion:** 2028-12-11
- **Target enrollment:** 1240 (ACTUAL)
- **Last updated:** 2025-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03984318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03984318, "Predictive Markers of Immune-related Adverse Events in Patients Treated With Immune Stimulatory Drugs". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03984318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*